Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Archives of Surgery (Chicago, Ill. : 1960)|January 14, 2004
Completion pancreatectomy for postoperative peritonitis after pancreaticoduodenectomy: early and late outcomeSylvie Gueroult, Yann Parc, Françoise Duron, et al.
Nuclear Medicine Communications|February 28, 2007
Stimulation test in the follow-up of thyroid cancer: plasma rhTSH levels are dependent on body weight, not endogenously stimulated TSH valuesPaolo Zanotti-Fregonara, Françoise Duron, Isabelle Keller, et al.
Clinical Endocrinology|February 17, 2007
Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?Elif Hindié, Paolo Zanotti-Fregonara, Françoise Duron, et al.
Clinical Nuclear Medicine|August 14, 2010
Pulmonary metastasis of struma ovarii: a case reportIsabelle Faugeron Ruel, Hélène Fierrard, Laetitia Vercellino, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2006
Which thyroid cancer patients need periodic stimulation tests?Paolo Zanotti-Fregonara, Alexandre Khoury, Françoise Duron, et al.
Endocrine-Related Cancer|October 5, 2007
Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcomeElif Hindié, Paolo Zanotti-Fregonara, Isabelle Keller, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2009
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumorsFrançoise Montravers, Khaldoun Kerrou, Valérie Nataf, et al.
Presse Medicale (Paris, France : 1983)|September 14, 2006
[PET in thyroid cancers]Jean-Noël Talbot, Françoise Montravers, Nassima Younsi, et al.
Diabetes|November 16, 2007
The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3Christine Bellanné-Chantelot, Claire Carette, Jean-Pierre Riveline, et al.
Human Molecular Genetics|February 5, 2013
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort studyJulien Thevenon, Abderrahmane Bourredjem, Laurence Faivre, et al.
Pageof 1